Myomo, Inc.

MYO ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $40.9M $32.6M $19.2M $15.6M $13.9M $7.6M $3.8M $2.4M
Cost of Revenue $14.0M $9.4M $6.1M $5.3M $3.5M $2.6M $1.4M $728.3K
Gross Profit $26.9M $23.2M $13.2M $10.3M $10.3M $5.0M $2.4M $1.7M
Gross Margin 65.7% 71.2% 68.5% 65.9% 74.4% 65.7% 63.0% 70.2%
Operating Expenses
Research & Development $6.9M $4.8M $2.6M $2.5M $2.6M $1.7M $1.7M $1.8M
SG&A Expense $14.0M $12.4M $18.8M $18.4M $18.0M $13.8M $11.5M $10.4M
Operating Income $-14.4M $-6.2M $-8.2M $-10.7M $-10.3M $-10.5M $-10.8M $-10.5M
Operating Margin -35.2% -19.1% -42.8% -68.6% -74.1% -138.5% -281.3% -430.8%
Interest Expense $218.8K $113.6K
Pretax Income $-15.1M $-5.8M $-8.0M $-10.7M $-10.3M $-11.6M
Income Tax Expense $504.5K $365.6K $156.0K $69.9K $88.9K
Net Income $-15.6M $-6.2M $-8.1M $-10.7M $-10.4M $-11.6M $-10.7M $-10.3M
Net Margin -38.1% -19.0% -42.3% -68.9% -74.9% -152.5% -279.1% -422.1%
EPS (Basic) $-0.37 $-0.16 $-0.28 $-0.38 $-0.47 $-0.92 $-5.20 $-6.30
EPS (Diluted) $-0.37 $-0.16 $-0.28 $-0.38 $-0.47 $-0.92 $-5.20 $-6.30
Shares Outstanding (Basic) 41.9M 37.8M 29.5M 28.2M 23.3M 18.4M 2.3M 1.7M
Shares Outstanding (Diluted) 41.9M 37.8M 29.5M 28.2M 23.3M 18.4M 2.3M 1.7M
Dividends Per Share
← Newer Page 1 of 2 Older →